Status:
COMPLETED
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
Lead Sponsor:
Stanford University
Conditions:
Biliary Disease
Pancreatic Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using two types of cur...
Detailed Description
The risks associated with the ERCP procedure will be explained to patients who meets the eligibility criteria. Consenting patients will be randomized to undergo Endoscopic retrograde cholangiopancreat...
Eligibility Criteria
Inclusion
- Patients undergoing ERCP for biliary and pancreatic conditions
- Age \> 18 years old
Exclusion
- Vulnerable patient groups including pregnant women
- Patients who are unable to consent
- Patients with known cholangitis
- Patients with known Carbapenem-Resistant Enterobacteriaceae (CRE) or any other multi-drug resistant organisms (MDRO) infection
- Surgically altered anatomy except for Billroth I
Key Trial Info
Start Date :
October 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2024
Estimated Enrollment :
319 Patients enrolled
Trial Details
Trial ID
NCT05429203
Start Date
October 25 2022
End Date
July 29 2024
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford hospital
Palo Alto, California, United States, 943305